Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$1.28 - $2.41 $1,498 - $2,822
1,171 Added 96.62%
2,383 $3,000
Q3 2023

Oct 30, 2023

BUY
$1.28 - $2.41 $1,498 - $2,822
1,171 Added 96.62%
2,383 $3,000
Q2 2023

May 21, 2024

SELL
$1.17 - $2.03 $46 - $81
-40 Reduced 3.19%
1,212 $1,000
Q2 2023

Jul 27, 2023

SELL
$1.17 - $2.03 $46 - $81
-40 Reduced 3.19%
1,212 $2,000
Q1 2023

May 21, 2024

BUY
$1.58 - $3.41 $494 - $1,067
313 Added 33.33%
1,252 $2,000
Q1 2023

Apr 27, 2023

BUY
$1.58 - $3.41 $494 - $1,067
313 Added 33.33%
1,252 $2,000
Q4 2022

May 21, 2024

BUY
$2.0 - $3.58 $1,878 - $3,361
939 New
939 $1,000
Q4 2022

Jan 31, 2023

BUY
$2.0 - $3.58 $140 - $250
70 Added 8.06%
939 $2,000
Q3 2022

Oct 21, 2022

BUY
$2.95 - $4.83 $2,563 - $4,197
869 New
869 $3,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $278M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.